Valeant Pharmaceuticals International Inc (NYSE:VRX)

198.46
Delayed Data
As of Mar 26
 +1.45 / +0.74%
Today’s Change
106.00
Today|||52-Week Range
206.84
+38.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Operating ActivitiesNet Income / Starting Line-20.3M122.6M276.7M508.1M
 
 
 
 
 
Depreciation401.1M412.3M437.7M353.5M
 
 
 
 
 
Total Other Cash Flow136.0M34.6M-105.7M245.5M
 
 
 
 
 
Funds From Operations526.8M548.0M683.5M1.1B
 
 
 
 
 
Funds From/For Other Operating Expenses42.5M167.1M66.2M374.3M
 
 
 
 
 
Net Cash Flow - Operating Activities484.3M380.9M617.4M749.1M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-76.3M249.7K-67.8M
 
 
 
 
Decrease In Investments0.000.000.00125.6M
 
 
Capital Expenditures-58.1M-114.5M-39.1M-71.9M
 
 
 
 
 
Fixed Asset Disposal1.4M1.4M1.5B-32.1M
 
 
 
 
 
Net Assets From Acquisitions -306.3M-70.1M-607.0M-88.8M
 
 
 
 
 
Net Cash Flow Investing-384.1M-270.1M760.3M-203.0M
 
 
 
 
 
 
FinancingShort Term Borrowings-3.5M-3.3M122.6K-2.0M
 
 
 
 
 
Long Term Borrowings350.7M51.4M544.8M587.2M
 
 
 
 
 
Long Term Debt Reduction-433.9M-123.5M-1.6B-1.6B
 
 
 
 
 
Net Proceeds Stock Sale3.5M3.6M3.8M5.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing1.2M6.8K15.9M-511.2K
 
 
 
 
 
Other Uses - Financing40.7M86.4M16.5M10.4M
 
 
 
 
 
Net Cash Flow - Financing-122.7M-158.2M-1.1B-1.0B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.5M1.9M-15.3M-13.3M
 
 
 
 
 
 
Net Change In Cash-22.5M-47.4M293.8M-465.8M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account